GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Market Cap

Daehan New Pharm Co (XKRX:054670) Market Cap : ₩108,493 Mil (As of Jun. 21, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Daehan New Pharm Co's share price for the quarter that ended in Mar. 2024 was ₩8320. Daehan New Pharm Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 14 Mil. Therefore, Daehan New Pharm Co's market cap for the quarter that ended in Mar. 2024 was ₩116,774 Mil.

Daehan New Pharm Co's quarterly market cap increased from Sep. 2023 (₩123,511 Mil) to Dec. 2023 (₩127,019 Mil) but then declined from Dec. 2023 (₩127,019 Mil) to Mar. 2024 (₩116,774 Mil).

Daehan New Pharm Co's annual market cap declined from Dec. 2021 (₩152,985 Mil) to Dec. 2022 (₩119,861 Mil) but then increased from Dec. 2022 (₩119,861 Mil) to Dec. 2023 (₩127,019 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Daehan New Pharm Co's Enterprise Value for Today is ₩116,990 Mil.


Daehan New Pharm Co Market Cap Historical Data

The historical data trend for Daehan New Pharm Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co Market Cap Chart

Daehan New Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145,967.12 176,844.78 152,984.77 119,861.46 127,019.47

Daehan New Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125,054.52 129,686.17 123,510.64 127,019.47 116,773.70

Competitive Comparison of Daehan New Pharm Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Daehan New Pharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daehan New Pharm Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daehan New Pharm Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Daehan New Pharm Co's Market Cap falls into.



Daehan New Pharm Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Daehan New Pharm Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=₩9050*14.0353
=₩127,019

Daehan New Pharm Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₩8320*14.0353
=₩116,774

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daehan New Pharm Co  (XKRX:054670) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Daehan New Pharm Co Market Cap Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Daehan New Pharm Co (XKRX:054670) Business Description

Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co (XKRX:054670) Headlines

No Headlines